Clinical Research Directory
Browse clinical research sites, groups, and studies.
Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1
Sponsor: University of Miami
Summary
H. pylori is an infection of the stomach that can cause chronic gastritis, gastric cancer and peptic ulcer disease. The goal of this study is to screen people for this infection and offer treatment for those who test positive for the infection. By treating those who are positive for H. pylori, there is an opportunity to prevent gastritis, peptic ulcer disease, and even gastric cancer.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
500
Start Date
2022-10-15
Completion Date
2027-11-06
Last Updated
2026-02-17
Healthy Volunteers
Yes
Interventions
PYTEST® 14C-Urea Breath Test
FDA-approved radiolabeled urea capsule used in the PYtest® 14C-Urea Breath Test for non-invasive detection of H. pylori. Participants ingest the capsule, and breath samples are collected and analyzed to determine infection status.
VOQUEZNA® Triple Pak®
FDA-approved combination therapy for H. pylori infection, consisting of: Vonoprazan tablets 20 mg (1 tablet twice daily for 14 days) Amoxicillin 500 mg (2 tablets twice daily for 14 days) Clarithromycin 500 mg (1 tablet twice daily for 14 days) Medications are dispensed by the study team at the time of diagnosis.
Locations (1)
University of Miami
Miami, Florida, United States